Impact of HPV Subtypes on Prognosis and Treatment in Oropharyngeal Cancers

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Observational study finds HPV-16 improves survival outcomes in oropharyngeal cancer, suggesting treatment strategies may need to adapt.

Patients with HPV-16 showed a remarkable one-year overall survival of 95.3% and disease-free survival of 90.7%, outperforming other subtypes.
The study involved 81 HPV-positive OPSCC patients, classified into groups based on HPV subtypes including HPV-16, HPV-18, and others.
HPV subtype variations may affect treatment response, with HPV-16 linked to the highest rates of complete responses and lower recurrence.
Findings highlight the importance of HPV subtypes in treatment planning for oropharyngeal cancers, paving the way for tailored therapeutic approaches.

Zeeshan et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Observational study finds HPV-16 improves survival outcomes in oropharyngeal cancer, suggesting treatment strategies may need to adapt.

Patients with HPV-16 showed a remarkable one-year overall survival of 95.3% and disease-free survival of 90.7%, outperforming other subtypes.
The study involved 81 HPV-positive OPSCC patients, classified into groups based on HPV subtypes including HPV-16, HPV-18, and others.
HPV subtype variations may affect treatment response, with HPV-16 linked to the highest rates of complete responses and lower recurrence.
Findings highlight the importance of HPV subtypes in treatment planning for oropharyngeal cancers, paving the way for tailored therapeutic approaches.

Zeeshan et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark